Pause in Covid-19 vaccine trial 'not necessarily a setback', Matt Hancock claims
INSUBCONTINENT EXCLUSIVE:
AstraZeneca Plc - which is working alongside the University of Oxford - has confirmed it had had to pause development of the vaccine "to
allow review of safety data"This article first appeared/also appeared in Mirror
